
Recorded on
March 13
|
![]() |
Sugar, We’re Going Down:
The Role of Continuous Glucose Monitoring
in the Management of Diabetes
|
Betsy Blake, PharmD, BCPS;
Director of Interprofessional Education and
Clinical Associate Professor,
UofSC COP; Co-Chair, Interprofessional Education for the
Health Sciences, UofSC
|
1.25 hours |
Recorded on
March 13
|
![]() |
Guideline Review and Case Evaluation of
Diabetes Mellitus in Older Adults
|
Karen McGee, PharmD, CDCES, BCGP;
Clinical Associate Professor, UofSC COP;
Clinical Pharmacist, Palmetto SeniorCare PACE
|
1.00 hour |
Recorded on
March 13
|
![]() |
Breathe Easier:
Updates in Lung Cancer Treatment
for the Non-Oncology Pharmacist
|
Megan Tran, PharmD;
Clinical Assistant Professor, UofSC COP;
Oncology Clinical Pharmacist, Prisma Health Richland
|
1.25 hours |
Recorded on
March 13
|
![]() |
How to Save a Life:
Assessing and Supporting Patients
with Opioid Use Disorders
|
Jordan Cooler, PharmD, BCPP;
Clinical Assistant Professor, UofSC COP;
Psychiatric Pharmacist, UofSC Student Health Center
|
1.25 hours |
Recorded on
March 13
|
![]() |
When You Are More Batman than Superman:
Pharmacists as First Responders in the Community
|
Kyle Weant, PharmD, BCPS, BCCCP, FCCP;
Clinical Assistant Professor, UofSC COP;
Emergency Medicine Clinical Pharmacy Specialist,
Prisma Health Richland
|
1.25 hours |
Recorded on March 24 | ![]() |
While You Were Quarantined:
2020 New Drug Update, Part 1
|
Andrew Mardis, PharmD, BCCP, BCPS
Affiliate Assistant Professor, UofSC COP;
Clinical Pharmacy Specialist;
Mechanical Circulatory Support & Advanced Heart Failure,
Prisma Health
|
1.00 hour |
Recorded on March 31 | ![]() |
While You Were Quarantined:
2020 New Drug Update, Part 2
|
Andrew Mardis, PharmD, BCCP, BCPS;
Affiliate Assistant Professor, UofSC COP;
Clinical Pharmacy Specialist;
Mechanical Circulatory Support & Advanced Heart Failure,
Prisma Health
|
1.00 hour |
Recorded on April 7 | ![]() |
It’s ta-CROH-limus, not tacro-LEE-mus:
Medication Errors in Solid Organ Transplant Recipients
|
Caitlin Mardis, PharmD, BCPS;
Clinical Assistant Professor and
Director of Continuing Education, UofSC COP
|
1.00 hour |
Recorded on April 14 | ![]() |
Investigating Drug Interactions Through the Lens of Adverse Events |
Cynthia Phillips, PharmD, CDCES;
Clinical Associate Professor, UofSC COP;
Clinical Pharmacist, Prisma Health Richland
|
1.00 hour |
Recorded on April 21 | ![]() |
CBD: Exploring Regulations, Trends, and a Potential Role in the Opioid Epidemic? |
Michaela Almgren, PharmD, MS;
Clinical Assistant Professor, UofSC COP
|
1.00 hour |
Pre-recorded | ![]() |
Primary Headache Disorders in the Community Setting | Carrie Lynch, PharmD; PGY1 Community Pharmacy Resident, UofSC COP/Hawthorne Pharmacy | 1.00 hour |
|
Hours | Pharmacists** |
Entire Program:
To Purchase the entire program,
click on "Purchase Now" below!
|
12 hours
|
$130 |
Individual Sessions
To purchase individual sessions, check the session(s) you would like to purchase on the list below!
|
1-12 hours | $15 per session |
- **PEEP Preceptors: You have received communication via email regarding discounted registration for the live program, this code will work for the Home Studies as well!
- Please note that fees will appear as “Learning Express” on your credit card statement
- Operating System: Windows, Mac OS and Linux
- Internet Browser: Internet Explorer 7.0 or higher; Mozilla Firefox 3.0 or higher; Google Chrome
- Computer Speakers or headphones connected to your computer
- Broadband Internet Connection: Cable, High-speed DSL or T1
- Monitor Screen Resolution: 320x480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint and HTML
Fee
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
Accreditation(s)
![]() |
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
- Compare FDA-approved devices for continuous glucose monitoring (CGM)
- Review current American Diabetes Association Standards of Care recommendations related to CGM
- Analyze data related to the benefits of CGM in the management of diabetes
- Recommend medication adjustments based on patient specific CGM data
Speaker(s)/Author(s)
Betsy Blake, PharmD, BCPS, FNAP
|
Activity Number
0062-0000-21-042-H01-P
CE Hours
Fee
- Review current American Diabetes Association Standards of Care recommendations specific to older adults
- List geriatric syndromes that should be evaluated at least yearly
- Utilize patient cases to discuss pharmacotherapy considerations in older adults with diabetes
- Compare differences in treatment and monitoring recommendations for diabetes care in older adults
Speaker(s)/Author(s)
Karen McGee, PharmD, CDCES, BCGP
|
Activity Number
0062-0000-21-043-H01-P
CE Hours
Fee
- Recommend appropriate screening for lung cancer
- Identify new medications and updated recommendations for treatment of early-stage and metastatic lung cancer
- Discuss the role of lung cancer biomarkers in treatment recommendations
- Recognize common medications used for supportive care in lung cancer patients
Speaker(s)/Author(s)
Megan Tran, PharmD
|
Activity Number
0062-0000-21-044-H01-P
CE Hours
Fee
- Assess patients for risk of suicide or harm using validated tools
- Recognize strategies to provide nonjudgmental support to patients and combat stigmas associated with substance use disorders
- Identify patients at risk for opioid overdose and counsel on the importance of naloxone
- Identify key resources related to substance use disorders to recommend and provide to patients and their family members
Speaker(s)/Author(s)
Jordan Cooler Haygood, PharmD, BCPP
|
Activity Number
0062-0000-21-045-H08-P
CE Hours
Fee
- Identify signs and symptoms of an acute ischemic stroke and initial treatment algorithms
- Assess available pharmacologic and non-pharmacologic modalities for the management of an opioid overdose
- Evaluate a patient for acute hypoglycemia and prioritize treatment strategies
- Describe the initial approach to emergent seizure activity
Speaker(s)/Author(s)
Kyle Weant, PharmD, BCPS, BCCCP, FCCP
|
Activity Number
0062-0000-21-046-H01-P
CE Hours
Fee
- Recall therapeutic agents that were FDA approved and came to market throughout 2020
- Identify each new therapeutic agent's indication, dosing, potential adverse effects, places in therapy, and unique characteristics
- Summarize clinical treatment guidelines that were published or updated in 2020
Speaker(s)/Author(s)
B. Andrew Mardis, PharmD, BCPS
|
Activity Number
0062-0000-21-048-H01-P
CE Hours
Fee
- Recall therapeutic agents that were FDA approved and came to market throughout 2020
- Identify each new therapeutic agent's indication, dosing, potential adverse effects, places in therapy, and unique characteristics
- Summarize clinical treatment guidelines that were published or updated in 2020
Speaker(s)/Author(s)
B. Andrew Mardis, PharmD, BCPS
|
Activity Number
0062-0000-21-049-H01-P
CE Hours
Fee
- Recognize common immunosuppressant agents and regimens utilized in solid organ transplant (SOT) recipients
- Identify key opportunities for medication errors to occur in SOT transplant recipients
- Determine the potential consequences of medication errors in SOT recipients
- Identify opportunities for pharmacists in all practice settings to improve medication safety in SOT recipients
Speaker(s)/Author(s)
Caitlin Mardis, PharmD, BCPS
|
Activity Number
0062-0000-21-050-H01-P
CE Hours
Fee
- Identify risk factors predisposing patients to drug interactions
- Analyze patient medication regimens that offer opportunities for intervention
- Examine the pharmacokinetic and pharmacodynamic mechanisms involved in drug interactions
- Strategize solutions for approaching potential adverse outcomes of drug interactions to improve patient health and safety
Speaker(s)/Author(s)
Cynthia Phillips, PharmD, CDCES
|
Activity Number
0062-0000-21-051-H01-P
CE Hours
Fee
- Discuss federal and state laws and regulations related to cannabidiol (CBD)
- Identify FDA-approved and off-label uses for CBD
- Compare and contrast commercially available CBD products
- Analyze literature related to the potential role of CBD in patients with substance use disorders
Speaker(s)/Author(s)
Michaela Almgren, PharmD, MS
|
Activity Number
0062-0000-21-052-H01-P
CE Hours
Fee
- Recognize the triggers and clinical presentations of each primary headache disorder
- Recall the appropriate preventative and abortive therapy options for each primary headache disorder
Speaker(s)/Author(s)
Carrie Lynch, PharmD
|
Activity Number
0062-0000-21-053-H01-P